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Abstract 
Purpose This pilot sought to determine feasibility of studying the impact on hypertension in over-the-road truck drivers who met with 
pharmacists for Medication Therapy Management (MTM) compared to those who did not.  
Design/methodology/approach Drivers were randomly assigned to control or treatment (MTM) group for 52 weeks. Drivers 
assigned to the MTM arm could receive services in person or via secure videoconferencing technology located in a private space at 
the trucking company. All subjects were provided education and received a blood pressure monitor and log for recording daily blood 
pressures.  
Findings Eleven drivers enrolled and seven drivers completed the study. The primary barriers to participation included unpredictable 
driver schedules and lack of access to MTM provider while on the road.  
Research limitations/implications This pilot study was limited by small sample size. Pharmacists were not available to meet with 
truckers “on demand.” Therefore, researchers are encouraged to test alternate opportunities to increase enrollment of drivers in 
studies and access to MTM services while drivers are on the road. 
Practical implications Hypertension is the second highest health-related cost burden, and over-the-road truck drivers have unique 
challenges that can make it difficult to attain blood pressure control.  Pharmacist-provided MTM has been shown to improve blood 
pressure control. Improving access to MTM, perhaps using a national network of pharmacists or technology from the road, may 
decrease morbidity and mortality in drivers. 
Originality/value This paper fulfills an identified need to study how to improve driver access to care to reduce cardiovascular-related 
morbidity and mortality. 
 
 
Background 
Hypertension affects over one-third of adults in the United 
States > 20 years of age (~ 78 million).1 Although it is well 
established that high blood pressure is the biggest 
contributor to cardiovascular disease (CVD) mortality in the 
U.S., control remains suboptimal.1,2  Just over one-half of U.S. 
adults have their blood pressure (BP) controlled (systolic BP 
<140 mmHg and diastolic BP <90 mmHg) despite widespread  
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efforts to promote awareness and treatment, along with the 
availability of low cost, effective antihypertensive agents.1 In 
addition, hypertension is a costly condition.  An analysis of a 
multi-employer database of 374,799 employees 
demonstrated hypertension in the workforce is the second 
highest cost burden for U.S. employers.3  Employers and 
payers of employee health benefits bear a substantial cost for 
the burden of hypertension in not only direct costs but also in 
indirect costs including absenteeism and presenteeism, with 
the overall economic burden of hypertension being slightly 
under $400 per eligible employee per year.3,4  According to 
the National Survey of U.S. Long-Haul Truck Driver Health and 
Injury the prevalence of hypertension in long-haul truck 
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drivers in 2010 is statistically similar to that of the 2010 U.S. 
adult working population (26.3% vs. 24.1%), yet the 
prevalence of obesity and current smoking are more than 
double  in long-haul truck drivers (69% vs. 31%, p < 0.01; and 
51% vs. 19%, p < 0.01, respectively), further increasing their 
overall risk of cardiovascular disease.5   
 
Companies providing services using commercial drivers have 
special challenges related to hypertension.  Not only do these 
companies face costs related to a driver’s health, but also 
specific dangers and liability associated with traffic accidents 
from impaired employees while driving including the risk of 
major accidents involving drivers who are suspected to have 
experienced myocardial infarctions while on the road.6, 7  In 
addition, other variables make it more challenging to provide 
optimal health care to long-haul truck drivers, including 
erratic and ever-changing driver schedules, access to timely 
health care services, and health insurance.6  In two recent 
surveys of long-haul truck drivers, 33-38% were not covered 
by health insurance, as opposed to 17% of the U.S. adult 
working population.5,6   Other factors impeding the optimal 
provision of health care to long-haul truck drivers are the lack 
of regular visits to health care providers  (70% had no regular 
health care visits) and delay in seeking care (up to 20% report 
waiting to reach home prior to seeking care).6 
 
In an effort to reduce risks of transportation mishaps, the U.S. 
Department of Transportation (DOT) has increased regulatory 
requirements and restrictions on commercial driver’s licenses 
(CDL).8  The DOT hypertension qualifications define drivers 
with systolic blood pressure (SBP) higher than 140 mmHg 
and/or diastolic blood pressure (DBP) over 90 mmHg as 
hypertensive.  The DOT further classifies qualifications and 
CDL certification according to severity of hypertension. CDL 
drivers must undergo frequent monitoring of blood pressure, 
with time limits for controlling high blood pressure before 
disqualification.  While this is an incentive for companies to 
maintain healthy employees, there is a cost associated with 
monitoring, medical visits and tests, and treatment to achieve 
control of hypertension.  As such, there is a need for targeted 
and novel interventions to improve the provision of optimal 
health care, including blood pressure management, to long-
haul truck drivers. 
 
Medication therapy management (MTM) is a service provided 
by qualified and credentialed pharmacists. MTM services 
have demonstrated positive results in identifying and 
resolving drug therapy problems and improving patient 
outcomes.9,10  Several studies have demonstrated that 
consultation with pharmacists can improve blood pressure 
control when focused on direct patient-centered care.11-17 In 
addition, added attention has been given to the superior 
prognostic value of out-of-office blood pressure values 
relative to office-based readings, with the upper limit of 
normal for home and ambulatory blood pressure being 
135/85 mmHg.18-20 Therefore, interventions which may 
improve ambulatory blood pressure control are worthy of 
further investigation, such as the use of “blood pressure 
load,” a novel approach to gauge ambulatory blood pressure 
control. Systolic and diastolic blood pressure loads are 
defined as the average probability a person would obtain a 
home systolic blood pressure reading greater than 135 mmHg 
and diastolic blood pressure reading greater than 85 mmHg 
respectively.21 
 
This pilot sought to determine feasibility of conducting a 
study to confirm or refute the operational hypothesis that 
over-the-road truck drivers who met with pharmacists (face-
to-face or through videoconferencing) for MTM would have 
lower blood pressure load (probability of obtaining a home 
systolic blood pressure reading greater than 135 mmHg and 
diastolic blood pressure readings greater than 85 mmHg) 
than those who did not receive MTM. Feasibility was 
assessed by evaluating the following questions in a sample of 
over-the-road drivers: 
 
1) Will over-the-road drivers enroll in and complete a 
12-month research study? 
2) Will drivers take, record, and submit daily blood 
pressure readings? 
3) To what extent will drivers randomized to receive 
MTM schedule and attend their appointments?  
4) Will drivers randomized to receive MTM elect to 
attend face-to-face or by video conferencing? 
5) What are the demographic and clinical characteristics 
of drivers enrolling in a study (e.g. caffeine intake, 
exercise habits, achievement of blood pressure 
goals, systolic and diastolic blood pressure loads)? 
 
This paper will describe feasibility of conducting a research 
study designed to confirm or refute the operational 
hypothesis that long-haul truck drivers who met with 
pharmacists (face-to-face or through videoconferencing) for 
MTM would have lower blood pressure load than those who 
did not receive MTM.  
 
Methods 
Study Setting 
Halvor Lines, Inc., headquartered in Superior, Wisconsin, is a 
moderate-sized trucking company that employs 
approximately 300 over-the-road drivers and operates 310 
power units and 850 trailers. They provide transportation and 
logistics services across the U.S. and Canada. Leadership of 
Halvor Lines, Inc. has created a focus on driver health in an 
http://z.umn.edu/INNOVATIONS                     2015, Vol. 6, No. 1, Article 193                           INNOVATIONS in pharmacy   2 
 
Clinical Experience PRACTICE-BASED RESEARCH 
 
effort to sustain a healthy productive workforce, and has 
previously partnered with the College of Pharmacy at the 
University of Minnesota Duluth Campus to promote health of 
drivers through health screenings and education. Essentia 
Health is a large integrated health system with hospitals and 
clinics in northern Minnesota, northern Wisconsin, North 
Dakota, and Idaho. MTM pharmacists participating in this 
study were located in the Internal Medicine department at 
Essentia Health First Street Clinic in Duluth, MN. 
 
Inclusion Criteria  
Eligible drivers included adults age 24 or older who possessed 
an active Commercial Driver’s License (CDL) by the 
Department of Transportation, and had a clinical diagnosis of 
hypertension. Drivers had to be be located or frequently 
traveled to the Halvor Lines Superior, WI Hub, be able to 
comply with required study appointments, and be able and 
willing to sign informed consent. 
 
Exclusion Criteria  
Drivers could not be enrolled in any other disease-state 
management (DSM) or similar program, or be enrolled or 
participating in any other medication therapy management 
program. 
 
Study design 
Eligible drivers were screened and enrolled by study 
investigators on site at the Halvor Lines Training Center 
located in Superior, WI. Target study enrollment was 60 
subjects, with 30 subjects randomly assigned to either a 
treatment or control group for a duration of 52 weeks.  
Enrollment occurred for the first six months of the study.  
 
All study subjects were seen at the Halvor Lines Superior Hub 
for initial evaluation by one of the study investigators. Using 
an unconstrained permuted blocks of random size approach, 
subjects were randomized to either the MTM group or “usual 
care” group. Drivers assigned to the MTM group received 
pharmacist-provided face-to-face MTM services, and could 
opt to receive MTM in-person at Essentia Health or via secure 
videoconferencing technology located at the Halvor Lines 
Training Center, connected to the MTM provider site at 
Essentia Health. Drivers randomized to “usual care” 
continued their usual medical care with their primary care 
physician, and did not receive MTM. 
 
Enrollment Visit 
During the enrollment visit the pharmacist investigator 
thoroughly explained the purpose of the study and study 
procedures, obtained signed informed consent, and obtained 
the subject’s medication and medical history, vital signs, and 
anthropometrics in the designated private space in the Halvor 
Lines Superior Hub training facility.  The treatment room was 
equipped with an Omron BP760 sphygmomanometer, body 
weight scale, stadiometer (height), and measuring tape. All 
participants were provided educational materials at 
enrollment explaining the importance of blood pressure 
control in lowering their cardiovascular risk and maintaining 
their CDL certification.  They also received resources to help 
them understand and manage hypertension, such as 
treatment and lifestyle information, suggested questions for 
their physician, and record-keeping tools.  Subjects in both 
groups were given an automatic home blood pressure 
monitor to check their blood pressure daily upon waking and 
instructed to submit their blood pressure readings to the 
secured on-site collection box monthly. The investigator then 
completed all necessary documentation and forwarded 
findings to the subject’s MTM pharmacist provider if assigned 
to the MTM group. A detailed description of procedures for 
initial and follow-up MTM visits and data collected can be 
found in Appendix A. Usual MTM fees were waived for 
subjects participating in the study.  
 
A survey was administered at the enrollment and final visits 
for all subjects. The survey measured the following domains: 
medication adherence; satisfaction with, perceptions of, and 
preferences for pharmacist-provided MTM; and driver 
demographic and health status variables. 
 
Recruitment 
Drivers were notified about the study through 
announcements at quarterly driver meetings, posting of study 
flyers at the Halvor training center, flyers placed in driver 
mailboxes at Halvor headquarters, and via the monthly driver 
newsletter. Potential subjects could call or e-mail study 
investigators to schedule an enrollment visit, and study 
investigators were available on-site for 4-8 hours per week 
for walk-in enrollment during the six-month study enrollment 
period. 
 
Subjects were given a $25 gift card upon enrollment in the 
study and an additional $50 gift card if they complete the 
final study visit. 
 
Evaluation Plan 
The feasibility of this pilot study was evaluated by collecting 
driver demographics through case report forms completed at 
enrollment and final visits, medical records, final visit survey, 
MTM visit case report forms, and driver blood pressure logs.  
Had the pilot study enrolled sufficient subjects (n=60) to 
answer the primary research question, mean systolic blood 
pressure load would have been compared between the MTM 
and “usual care” groups. 
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Statistical Analysis 
Data were analyzed using the Statistical Package for the 
Social Sciences (SPSS, Version 20).  Demographic 
characteristics of the participants were calculated using 
descriptive statistics.  Related-samples Wilcoxon signed rank 
or McNemar’s test were used as appropriate to test for 
differences between enrollment visit and final visit driver 
demographic and clinical characteristics.   
 
This study was approved by both the Essentia Health and 
University of Minnesota Institutional Review Boards, and was 
funded by a grant from Daiichi Sankyo, LTD. 
 
Results 
Enrollment and Retention 
Despite a variety of recruitment efforts (attending quarterly 
driver meetings, posting study flyers, placing study flyers in 
mailboxes and in the monthly newsletter, and investigator 
presence on site at least four hours weekly during 
enrollment), only eleven drivers enrolled in the study, which 
was an insufficient sample size to answer the primary study 
question. Seven of the eleven enrolled subjects completed a 
final study visit. 
 
Subject Demographics and Clinical Characteristics 
Demographic and clinical characteristics of subjects at 
enrollment and final visit are displayed in Table 1.  The 
majority of participants were male with mean age of 56 years 
at enrollment, ranging from 38 to 73 years old.  All 
participants were on at least one antihypertensive 
medication, and most had controlled blood pressure, with an 
average systolic and diastolic blood pressure at enrollment of 
129.6 mmHg and 83.6 mmHg respectively.  Drivers enrolled in 
the study ranged from newly diagnosed (11 days prior to 
enrollment) to having hypertension for 35 years.  No 
differences were found between enrollment and final visit 
characteristics for the seven individuals who completed the 
study.   
 
 “Home” Blood Pressure Monitoring 
Individual results of home blood pressure monitoring are 
shown in Table 2.  Two drivers submitted no logs. Of the nine 
that did submit blood pressure logs, no driver completed 
blood pressure logs for all days of the study, with an average 
completion of 146 days (s.d. 118 days; range 0-296 days).  
The grand mean of drivers’ average home blood pressure 
readings over the course of the year were 122.8 mmHg (s.d. 
9.3) systolic and 76.9 mmHg (s.d. 5.8) diastolic. Of the nine 
drivers submitting logs, average systolic and diastolic loads 
were 15.3% (s.d. 19.6%, range 0-61.5%) and 13.7% (s.d. 
14.3%, range 0-32.1%) respectively.   
 
Barriers to scheduling/completing MTM and final visits 
Per protocol, each of the MTM group subjects should have 
attended at least one initial and two follow-up MTM 
appointments. Four out of the six subjects randomized to the 
MTM group completed an initial MTM appointment; three 
completed face-to-face visits and one via teleconference. No 
subjects completed a follow-up MTM visit. An attempt was 
made at the end of the initial MTM visit to schedule a follow 
up appointment; however, each subject declined due to 
variability and uncertainty in work schedule. Three separate 
attempts were made over several months to contact subjects 
for initial or follow-up MTM visit. In most attempts to contact 
subjects, voicemail messages were left but not responded to. 
One subject discontinued employment at the company and 
withdrew from the study. The few subjects who were 
successfully contacted were on the road and either cited 
uncertainty about when they would be back in the area, or 
that they would be available on a weekend or evening in 
which no MTM pharmacist was available. One follow-up 
MTM visit was scheduled, but the subject did not show up. 
 
Seven out of eleven subjects completed final study visits. Of 
those who did not complete a final study visit, one subject 
confirmed he no longer worked for the company, and three 
others were unreachable and did not return multiple 
messages left at their preferred contact numbers/emails. 
 
Discussion 
This pilot study attempted to enroll long-haul truck drivers in 
a study comparing pharmacist-provided MTM and usual care 
to gauge the impact of a pharmacist intervention on blood 
pressure control. Our results reflect an inability to enroll an 
adequate size sample of drivers in this type of study, to 
schedule drivers and have them maintain health care 
appointments with pharmacists, and to have drivers submit 
self-monitored blood pressure logs. Barriers to scheduling 
and enrollment, and the implications for further studies and 
health care provision for drivers are discussed below.  
 
Scheduling Barriers 
Given variability and unpredictability of driver schedules, it 
was challenging to enroll drivers in the study and schedule 
any appointment in advance unless a driver was not 
scheduled to work and was residing in the local area. Many 
drivers do not live within close proximity of the local hub, so 
even if they were not on the road for work, many would likely 
not be in the area. Presumably this scheduling difficulty is not 
isolated to participation in a research study, but also inhibits 
drivers accessing health care services efficiently when 
needed.22 Providing access through mobile technology (e.g. 
smart phone) that would allow virtual visits at the driver’s 
convenience while a driver was out on the road may be an 
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option. The ability to upload pertinent data (e.g. blood 
pressures or blood sugars) could also aid in the ability to 
provide care for drivers while on the road. Experience at 
Kaiser Permanente suggests that connected health 
technologies have positive impacts on those who otherwise 
may not access traditional care23. Another option could be 
connecting drivers with a convenient national network of 
MTM providers with “on call” availability or flexible schedules 
to meet drivers’ needs, given drivers’ variable and ever-
changing schedules. Rolling Strong is one example of a 
company aiming to improve driver health through connecting 
drivers nationally with biometric screenings across a chain of 
pharmacies, phone health education and coaching, and 
exercise equipment designed for use in a truck  
(http://rollingstrong.com/2015/). 
 
Enrollment Barriers 
Aside from the scheduling difficulties described above, it is 
unclear what role that MTM being provided as part of a 
“study” impeded driver participation, i.e., would drivers have 
been more likely to enroll in an MTM program if these 
services were provided outside the realm of a “research 
study?” Drivers’ livelihoods are dependent on maintaining 
their CDL. Because drivers need to meet blood pressure goals 
to maintain their CDL, they may experience fear of “being 
found out” that their blood pressure is not at goal.  Despite 
repeated assurances that information obtained through their 
participation in the study would be kept in strict confidence 
and not shared with their employer, this concern may have 
persisted, leading to driver hesitation to participate in the 
project. 
 
During the recruitment period of the study to the present, 
Halvor Lines hired a health and wellness coordinator who is 
present full time on site at the Superior, WI hub. According to 
the health and wellness coordinator, the average life 
expectancy for an over-the-road driver is 61 years old, which 
is 14 years less than the average worker.  The median age for 
a driver at Halvor Lines is 52 years old. The coordinator’s 
programs at Halvor Lines have been primarily based on diet 
modification such as eating a balance of macronutrients, 
watching sodium intake, and increasing water intake, and 
exercise plans based on what drivers have access to over the 
road. Most programs are run for twelve weeks. As a 
company, Halvor Lines employees have lost over 2100 
pounds in just over a year, with a total of 111 participants. 
Out of these 111 participants, over sixty self-report that they 
have either cut back doses or gone off medications because 
of improved health. The challenge with this group of 
participants is getting them to the hub for their initial weigh-
in and measurements.  Once they do the initial weigh-in, each 
week the driver will self-report his/her weight via phone.  
Final measurements and weigh-ins are then done after the 12 
weeks is over.  Weekly coaching calls are set-up to help with 
the process. In addition, drivers report they like having access 
to someone on site and by phone, as it is more convenient for 
them.24 It is unclear what impact the wellness programs and 
availability of an on-site wellness coordinator had on study 
enrollment, ongoing participation, and in study subjects’ data 
(e.g. BMI, blood pressure). Similar strategies to those used by 
the health and wellness coach could be beneficial when 
providing health care services to driver populations.  
 
Limitations 
This pilot study was limited by the small pool of potential 
study subjects available, and that the pool came from only 
one trucking company. Pharmacists were not available to 
meet with truckers “on demand” or outside of the MTM 
pharmacists’ normal business hours. 
 
Conclusion 
A study protocol that requires truck drivers to schedule 
appointments at a specific time and place did not prove 
feasible in this project. Future research using alternative 
methods of study enrollment, study protocol design, health 
promotion, subject self-reporting of data and access to care 
(e.g. telehealth from the road) are needed to determine what 
interventions are most effective to reduce cardiovascular 
morbidity and mortality in over-the-road truckers.  Alternate 
strategies to provide health care for over-the-road truckers 
may improve access and utilization.   
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Appendix A 
 
Initial MTM and follow-up visits  
Subjects randomized to the MTM group were required to meet with the pharmacist MTM provider at least every four 
months, or more frequently as clinically indicated. At each visit for subjects in Group 2, the assigned MTM pharmacist 
conducted a standardized MTM visit and systematic process that: 
¨   Assessed all of the patient’s drug-related needs 
¨   Identified drug therapy problems 
¨   Established therapeutic goals 
¨   Designed a medication therapy care plan 
¨   Conducted follow-up visits to evaluate progress 
¨   Communicated information to the patient’s physician 
  
During this process each of the patient’s medications underwent scrutiny for: 
¨   Assessment of proper indication 
o   Is the drug being used unnecessary? 
o   Is additional drug therapy needed? 
¨   Effectiveness of treatment 
o   Is the current drug therapy is ineffective? 
o   Is the dose is too low to produce the desired response? 
¨   Safety 
o   Is there an adverse drug reaction present? 
o   Is the current drug dosage too high? 
¨   Convenience 
o   Is the patient adherent to the therapy? 
o   Are there barriers to the patient’s ability to comply with therapy, (e.g., physical, and financial)? 
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Table 1. Demographic and clinical characteristics at enrollment and final visit 
Characteristics Enrollment visit (n=11) Final visit (n=7) 
SBP average  129.6 (s.d. 10.14) 129.1 (s.d. 14.88) 
DBP average  83.6 (s.d. 7.56) 79.3 (s.d. 10.65) 
Pulse average 71.6 (s.d. 11.02) 63.2 (s.d. 11.04) 
DOT HTN 
Classification 
Normal 8 (72.7%) 5 (71.4%) 
Stage 1 3 (27.3%) 2 (28.6%) 
BMI 37.7 (s.d. 5.596) 33.1 (s.d. 3.38) 
BMI Classification Normal 0 (0%) 0 (0%) 
Overweight 0 (0%) 1 (14.3%) 
Obese 11 (100%) 6 (85.7%) 
Self-reported 
Gender Male 10 (90.9%) 7 (100%) 
Female 1 (9.1%) 0 (0%) 
Age 56 (s.d. 10.173) 61 (s.d. 8.426) 
Highest level of 
education 
Less than high school 1 (9.1%) 1 (14.3%) 
High school diploma 4 (36.4%) 2 (28.6%) 
Some college or technical 
degree 
5 (45.5%) 3 (42.9%) 
Professional or graduate 
degree 
1 (9.1%) 1 (14.3%) 
Ethnicity  Caucasian 11 (100%) -- 
Duration of HTN (years) 12.3 (s.d. 12.42) -- 
Average # of hypertension medications 1.6 (s.d. 0.6876) 1.4 (s.d. 0.53) 
Self-rated health Poor 1 (9.1%) 0 (0%) 
Fair 3 (27.3%) 0 (0%) 
Good 5 (45.5%) 4 (57.1%) 
Very good 2 (18.2%) 2 (28.6%) 
Excellent 0 (0%) 1 (14.3%) 
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Diabetes 3 (27.3%) 4 (57.1%) 
Metabolic Syndrome 6 (54.5%) 1 (14.3%) 
Kidney Disease  2 (18.2%) 0 (0%) 
Smoking No 4 (36.4%) 3 (42.9%) 
Yes 3 (27.3%) 0 (0%) 
Former 4 (36.4%) 4 (57.1%) 
Alcohol Use 8 (72.7%) 5 (71.4%) 
Caffeine Use 10 (90.9%) 7 (100%) 
Stimulant Use 1 (9.1%) 1 (14.3%) 
Aerobic Exercise  8 (72.7%) 6 (85.7%) 
Minutes/week for those exercising 146 (s.d. 151.67) 128 (s.d. 88.99) 
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Table 2. Home blood pressure monitoring for each participant 
 
Participant % blood 
pressure 
readings 
submitted 
(days) 
Average systolic 
blood pressure 
mmHg 
Average 
diastolic blood 
pressure mmHg 
Systolic blood 
pressure load (% 
readings above 
135 mmHg) 
Diastolic blood 
pressure load (% 
readings above 
85 mmHg) 
1 18.9% (69) 117.8 71.9 0% 0% 
2 81.1% (296) 115.2 73.6 6.8% 6.1% 
3 51.5% (188) 106.9 67.4 1.6% 1.1% 
4 0% (0) -- -- -- -- 
5 11.2% (41) 129.3 82.1 26.8% 22% 
6 91.5% (334) 130.7 75.8 21.3% 1.2% 
7 51.2% (187) 125.7 83.0 7% 31% 
8 0% (0) -- -- -- -- 
9 64.1% (234) 136.6 82.3 61.5% 28.6% 
10 53.7% (196) 116.4 82.7 1.5% 32.1% 
11 16.7% (61) 126.7 73.5 11.5% 1.6% 
 
 
 
 
 
 
Table 3. MTM and Final Visits 
 
Visit Type Visits Anticipated Visits Completed Contact attempts 
MTM 18 (6 subjects: 1 initial and 2 
follow-ups per protocol) 
4 initial visits (3 face-to-face, 1 
teleconference), 0 follow-up 
visits 
18  
Final (12-month)  11 7 35 
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Table 4. Final visit contact attempts 
 
Subject C1 C2 C3 C4 C5 C6 #C Final visit completed? 
1 E E E E E   5 No 
2 P P P P     4 Yes 
3 P P         2 Yes 
4 P          1 No - no longer at Halvor 
5 P/E P P P P P 7 No 
6 P P         2 Yes 
7 P P         2 Yes 
8 P P P P P   5 No 
9 P P P       3 Yes 
10 P P         2 Yes 
11 P P         2 Yes 
C = contact (C1= first contact; C2 = second contact, etc.); #C = total number of contact(s)/contact attempts;  
P = phone call or voicemail left; E = Email. 
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